Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Patent
1990-07-26
1991-12-24
Friedman, Stanley J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
514573, A61K 3119, A61K 31215, A61K 31557
Patent
active
050753347
ABSTRACT:
Amethod for inducing decrease in potassium ion concentration in the blood which comprises administering, to a subject having an increased potassium ion concentration in the blood, a prostanoic acid derivative in an amount effective in inducing decrease in potassium ion concentration in the blood wherein said concentration is increased or for improving extracorporeal excretion of potassium ion in the blood which comprises administering, to a subject having an increased potassium ion concentration in the blood, a prostanoic acid derivative in an amount effective in improving extracorporeal excretion of potassium ion concentration is increased.
REFERENCES:
Chem. Abst. 90-118674J.
Anggard, Acta Physical. Scand., 1966, 66, pp. 509-510.
Robert et al., Prostaglandins, vol. 11, No. 5, May 1976, pp. 809-828.
Osama Hiroyoshi
Ueno Ryuji
Friedman Stanley J.
K.K. Ueno Seiyaku Oyo Kenkyujo
LandOfFree
Excretion of potassium ion by prostanoic acid derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Excretion of potassium ion by prostanoic acid derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Excretion of potassium ion by prostanoic acid derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-43822